• Most Popular
  • Most Shared

CORRECTED - CORRECTED-(Aug 31)-UPDATE 1-Pozen says FDA accepts Vimovo NDA

Tue Sep 1, 2009 3:05pm EDT

Stocks

   

(Corrects second paragraph in Aug. 31 story to clarify the drug Vimovo contains an immediate release form of AstraZeneca's esomeprazole, not the enteric-coated formulation found in Nexium)

* Pozen to get $10 mln payment from AstraZeneca

* Shares rise 11 pct

Aug 31 (Reuters) - Pozen Inc (POZN.O) said U.S. health regulators have accepted a marketing application for its experimental pain drug Vimovo, triggering a $10 million milestone payment from AstraZeneca (AZN.L) to Pozen.

The drug Vimovo is a fixed-dose combination of the enteric-coated anti-inflammatory naproxen and an immediate release formulation of AstraZeneca's esomeprazole.

Pozen shares were up 9 percent to $7.03 in morning trade Monday on Nasdaq. They touched a high of $7.18 in early trade. (Reporting by Shailesh Kuber in Bangalore; Editing by Gopakumar Warrier)



More from Reuters

An Iranian woman supporting former prime Mmnister Mirhossein Mousavi, who is a candidate for the upcoming presidential elections, covers her face with his picture during a pre-election gathering at a stadium in Tehran June 9, 2009. REUTERS/Damir Sagolj

A nation on the brink?

Nukes may not be the only ticking clock in Iran. The reformist movement is swelling and "it is going to get very violent."  Full Article 

A security guard walks past cars in a Geely Automobile Holdings Ltd. factory in a Shanghai suburb September 28, 2006.REUTERS/Aly Song

China in auto power play

It might not shake up the industry just yet, but China's interest in Volvo and Saab is the start of something big in global autos.  Commentary | Video